< Back to previous page
Researcher
Benoit Beuselinck
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Feb 2011 → Today
Projects
1 - 6 of 6
- Response prediction in metastatic clear-cell renal cell carcinoma treated with angiogenesis and/or immune checkpoint inhibitorsFrom1 Oct 2020 → TodayFunding: Foundations, funds and other with scientific goal
- Medication-related osteonecrosis of the jaw (MRONJ) - Balancing treatments benefits and risksFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- RESPONSE PREDICTION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TARGETED THERAPY AND/OR IMMUNE CHECKPOINT INHIBITORSFrom5 Dec 2019 → 30 Sep 2021Funding: BOF - projects
- RESPONSE PREDICTION IN METASTATIC RENAL CELL CARCINOMA TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTORTARGETED THERAPY AND/OR IMMUNE CHECKPOINT INHIBITORSFrom1 Oct 2019 → TodayFunding: FWO fellowships
- Patient selection strategies throughout the renal cell carcinoma disease spectrumFrom1 Aug 2019 → 6 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Molecular profiling of clear-cell renal cell carcinoma and prediction of response to targeted therapies against the vascular endothelial growth factor receptor, immune checkpoint inhibitors and mTOR inhibitors in the metastatic setting.From1 Oct 2016 → 30 Sep 2020Funding: FWO fellowships, Nonprofit institution or equivalents
Publications
91 - 100 of 152
- Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab(2018)
Authors: Tom van Cann, Patrick Schöffski, Paul Clement, Oliver Bechter, Isabel Spriet, Constantinus Politis, Joseph Schoenaers, Herlinde Dumez, Patrick Neven, Kristiaan Nackaerts, et al.
Pages: 100 - 109 - Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors(2018)
Authors: Tom van Cann, Annelies Verbiest, Paul Clement, Oliver Bechter, Ludo Willems, Isabel Spriet, Constantinus Politis, Joseph Schoenaers, Herlinde Dumez, Patrick Neven, et al.
Pages: 869 - 878 - Non-Surgical Ablative Treatment of Distant Extracranial Metastases for Renal Cell Carcinoma: A Systematic Review(2018)
Authors: Gert De Meerleer, Maarten Albersen, Benoit Beuselinck
Pages: 57 - 67 - Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)(2018)
Authors: Benoit Beuselinck
Pages: 31 - 36 - 2002-2016: Fourteen years of euthanasia in Belgium: First-line observations by an oncologist(2017)
Authors: Benoit Beuselinck
Pages: 101 - 113 - Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma(2017)
Authors: Benoit Beuselinck
Pages: 403 - 410 - Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category(2017)
Authors: Benoit Beuselinck
Pages: 970 - 978 - Characterizing the outcomes of metastatic papillary renal cell carcinoma(2017)
Authors: Benoit Beuselinck
Pages: 902 - 909 - A Case of Severe Acute Cardiac Failure on Sunitinib After Left-Sided Thoracal Radiation Therapy(2017)
Authors: Patrick Schöffski, Johan Van Cleemput, Erik Van Limbergen, Kevin Punie, Hans Wildiers, Benoit Beuselinck
Pages: e155 - e158 - Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium(2017)
Authors: Benoit Beuselinck
Pages: 204 - 209